1192355-49-9

Upstream product

• 155377-05-2 6-(trifluoromethyl)pyridine-2-carboxylic acid methyl ester 
• 39890-95-4 2-chloro-6-trifluoromethylpyridine 
• 454-89-7 3-Trifluoromethylbenzaldehyde 
• 461-82-5 4-(trifluoromethoxy)aniline 
• 1192356-10-7 (+/-)-3-[1-methyl-1-(6-trifluoromethyl-pyridin-2-yl)-ethylamino]-1-(4-trifluoromethoxy-phenyl)-5-(3-trifluoromethyl-phenyl)-1,5-dihydro-pyrrol-2-one 
• 1032524-72-3 (+/-)-5-(3-trifluoromethyl-phenyl)-1-(4-trifluoromethoxy-phenyl)-3-(4-trifluoromethoxy-phenylamino)-1,5-dihydro-pyrrol-2-one 
• 1032526-56-9 (+/-)-1-(4-trifluoromethoxy-phenyl)-5-(3-trifluoromethyl-phenyl)-pyrrolidine-2,3-dione 
• 1192356-24-3 N-[1-methyl-1-(6-trifluoromethyl-pyridin-2-yl)-ethyl]-acetamide 
• 1192356-25-4 1-methyl-1-(6-trifluoromethyl-pyridin-2-yl)-ethylamine 
• 1192356-23-2 2-(6-trifluoromethyl-pyridin-2-yl)-propan-2-ol 
• 75-24-1 trimethylaluminum 

Relevant academic research and scientific papers

Boronate urea activation of nitrocyclopropane carboxylates

Boronate ureas operate as catalysts for the activation of nitrocyclopropane carboxylates in nucleophilic ring-opening reactions. A variety of amines were found to open the urea-activated nitrocyclopropane carboxylates, generating highly useful nitro ester

1,5-DIPHENYL-PYRROLIDIN-2-ONE COMPOUNDS AS CB-1 LIGANDS

CB-1 receptor inverse agonist compounds of Formula and pharmaceutical compositions for the treatment of obesity or cognitive impairment associated with schizophrenia.